Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1988;99:100–110.

Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.

J Davignon 1, D Bouthillier 1, A C Nestruck 1, C F Sing 1
PMCID: PMC2376437  PMID: 3503432

Full text

PDF
100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  2. Alvarez C., Orejas A., Gonzalez S., Diaz R., Colomo L. F. Reference intervals for serum lipids, lipoproteins, and apoproteins in the elderly. Clin Chem. 1984 Mar;30(3):404–406. [PubMed] [Google Scholar]
  3. Asakawa J., Takahashi N., Rosenblum B. B., Neel J. V. Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet. 1985;70(3):222–230. doi: 10.1007/BF00273446. [DOI] [PubMed] [Google Scholar]
  4. Boerwinkle E., Visvikis S., Welsh D., Steinmetz J., Hanash S. M., Sing C. F. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet. 1987 Jul;27(3):567–582. doi: 10.1002/ajmg.1320270310. [DOI] [PubMed] [Google Scholar]
  5. Bouthillier D., Sing C. F., Davignon J. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res. 1983 Aug;24(8):1060–1069. [PubMed] [Google Scholar]
  6. Cumming A. M., Robertson F. W. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet. 1984 Apr;25(4):310–313. doi: 10.1111/j.1399-0004.1984.tb01995.x. [DOI] [PubMed] [Google Scholar]
  7. Davignon J., Gregg R. E., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988 Jan-Feb;8(1):1–21. doi: 10.1161/01.atv.8.1.1. [DOI] [PubMed] [Google Scholar]
  8. Ehnholm C., Lukka M., Kuusi T., Nikkilä E., Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res. 1986 Mar;27(3):227–235. [PubMed] [Google Scholar]
  9. Glueck C. J., Gartside P. S., Steiner P. M., Miller M., Todhunter T., Haaf J., Pucke M., Terrana M., Fallat R. W., Kashyap M. L. Hyperalpha- and hypobeta-lipoproteinemia in octogenarian kindreds. Atherosclerosis. 1977 Aug;27(4):387–406. doi: 10.1016/0021-9150(77)90159-9. [DOI] [PubMed] [Google Scholar]
  10. Gregg R. E., Zech L. A., Schaefer E. J., Brewer H. B., Jr Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science. 1981 Feb 6;211(4482):584–586. doi: 10.1126/science.7455696. [DOI] [PubMed] [Google Scholar]
  11. Gregg R. E., Zech L. A., Schaefer E. J., Stark D., Wilson D., Brewer H. B., Jr Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 1986 Sep;78(3):815–821. doi: 10.1172/JCI112645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heckers H., Burkard W., Schmahl F. W., Fuhrmann W., Platt D. Hyper-alpha-lipoproteinemia and hypo-beta-lipoproteinemia are not markers for a high life expectancy. Serum lipid and lipoprotein findings in 103 randomly selected nonagenarians. Gerontology. 1982 May-Jun;28(3):176–202. doi: 10.1159/000212531. [DOI] [PubMed] [Google Scholar]
  13. Kageyama N. A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system. Clin Chim Acta. 1971 Feb;31(2):421–426. doi: 10.1016/0009-8981(71)90413-x. [DOI] [PubMed] [Google Scholar]
  14. Kameda K., Matsuzawa Y., Kubo M., Ishikawa K., Maejima I., Yamamura T., Yamamoto A., Tarui S. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis. 1984 May-Jun;51(2-3):241–249. doi: 10.1016/0021-9150(84)90171-0. [DOI] [PubMed] [Google Scholar]
  15. Lenzen H. J., Assmann G., Buchwalsky R., Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem. 1986 May;32(5):778–781. [PubMed] [Google Scholar]
  16. Lussier-Cacan S., Bouthillier D., Davignon J. Apo E allele frequency in primary endogenous hypertriglyceridemia (type IV) with and without hyperapobetalipoproteinemia. Arteriosclerosis. 1985 Nov-Dec;5(6):639–643. doi: 10.1161/01.atv.5.6.639. [DOI] [PubMed] [Google Scholar]
  17. Mahley R. W., Angelin B. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv Intern Med. 1984;29:385–411. [PubMed] [Google Scholar]
  18. Nestruck A. C., Bouthillier D., Sing C. F., Davignon J. Apolipoprotein E polymorphism and plasma cholesterol response to probucol. Metabolism. 1987 Aug;36(8):743–747. doi: 10.1016/0026-0495(87)90110-7. [DOI] [PubMed] [Google Scholar]
  19. Reardon M. F., Nestel P. J., Craig I. H., Harper R. W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 1985 May;71(5):881–888. doi: 10.1161/01.cir.71.5.881. [DOI] [PubMed] [Google Scholar]
  20. Reardon M. F., Poapst M. E., Uffelman K. D., Steiner G. Improved method for quantitation of B apoprotein in plasma lipoproteins by electroimmunoassay. Clin Chem. 1981 Jun;27(6):892–895. [PubMed] [Google Scholar]
  21. Richterich R., Dauwalder H. Zur Bestimmung der Plasmaglucosekonzentration mit der Hexokinase-Glucose-6-Phosphat-Dehydrogenase-Methode. Schweiz Med Wochenschr. 1971 May 1;101(17):615–618. [PubMed] [Google Scholar]
  22. Rosseneu M., Vinaimont N., Vercaemst R., Dekeersgieter W., Belpaire F. Standardization of immunoassays for the quantitation of plasma Apo B protein. Anal Biochem. 1981 Sep 1;116(1):204–210. doi: 10.1016/0003-2697(81)90345-6. [DOI] [PubMed] [Google Scholar]
  23. Sampson E. J., Demers L. M., Krieg A. F. Faster enzymatic procedure for serum triglycerides. Clin Chem. 1975 Dec;21(13):1983–1985. [PubMed] [Google Scholar]
  24. Schaefer E. J., Gregg R. E., Ghiselli G., Forte T. M., Ordovas J. M., Zech L. A., Brewer H. B., Jr Familial apolipoprotein E deficiency. J Clin Invest. 1986 Nov;78(5):1206–1219. doi: 10.1172/JCI112704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schmidt S. B., Wasserman A. G., Muesing R. A., Schlesselman S. E., Larosa J. C., Ross A. M. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1459–1462. doi: 10.1016/0002-9149(85)90953-1. [DOI] [PubMed] [Google Scholar]
  26. Sing C. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985 Mar;37(2):268–285. [PMC free article] [PubMed] [Google Scholar]
  27. Utermann G., Hardewig A., Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet. 1984;65(3):237–241. doi: 10.1007/BF00286509. [DOI] [PubMed] [Google Scholar]
  28. Utermann G., Hees M., Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 1977 Oct 13;269(5629):604–607. doi: 10.1038/269604a0. [DOI] [PubMed] [Google Scholar]
  29. Utermann G., Kindermann I., Kaffarnik H., Steinmetz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet. 1984;65(3):232–236. doi: 10.1007/BF00286508. [DOI] [PubMed] [Google Scholar]
  30. Utermann G., Pruin N., Steinmetz A. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet. 1979 Jan;15(1):63–72. [PubMed] [Google Scholar]
  31. Weisgraber K. H., Rall S. C., Jr, Mahley R. W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981 Sep 10;256(17):9077–9083. [PubMed] [Google Scholar]
  32. Zannis V. I., Breslow J. L. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry. 1981 Feb 17;20(4):1033–1041. doi: 10.1021/bi00507a059. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES